详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK Inhibitor

文献详情

资源类型：

作者：

机构： [1]Sun Yat Sen Univ, Canc Ctr, Dongfeng Rd East, Guangzhou, Guangdong, Peoples R China; [2]Acad Mil Med Sci, Affiliated Hosp, Beijing, Peoples R China; [3]Zhejiang Canc Hosp, Zhejiang, Peoples R China; [4]Wuhan Univ, Renmin Hosp, Wuhan, Hubei, Peoples R China; [5]Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [6]Third Mil Med Univ, Res Inst Surg, Chongqing, Peoples R China; [7]Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China; [8]Xiangya Sch Med, Hunan Canc Hosp, Changsha, Hunan, Peoples R China; [9]Xiangya Sch Med, Affiliated Canc Hosp, Changsha, Hunan, Peoples R China; [10]Sun Yat Sen Univ, Dept Med Oncol, Canc Ctr, Guangzhou, Guangdong, Peoples R China

出处：

ISSN：

关键词： Pulmonary sarcomatoid carcinoma anaplastic lymphoma kinase rearrangement clinical pathologic characteristics frequency

语种：

WOS：

中科院(CAS)分区：

出版当年[2017]版：

大类 | 2 区医学

小类 | 2 区肿瘤学 2 区呼吸系统

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学 1 区呼吸系统

第一作者：

第一作者机构： [1]Sun Yat Sen Univ, Canc Ctr, Dongfeng Rd East, Guangzhou, Guangdong, Peoples R China;

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK Inhibitor [2]非小细胞肺癌ALK、 ROS1及RET融合基因检测与临床特性的相关性分析 [3]Extended radical resection and chest wall reconstruction for a pulmonary sarcomatoid carcinoma: a case report [4]Case Report: Advanced pulmonary sarcomatoid carcinoma with adrenal gland metastasis after sintilimab combined with anlotinib treatment [5]Survival Analysis and Prediction Model for Pulmonary Sarcomatoid Carcinoma Based on SEER Database [6]The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2. [7]Toripalimab Combined With Bevacizumab,Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma [8]Effect of histological subtype on the efficacy of perioperative chemotherapy in pulmonary sarcomatoid carcinoma: a retrospective study based on SEER population [9]Clinical and Pathologic Characteristics Predicted the Postoperative Recurrence and Progression of Pituitary Adenoma: A Retrospective Study with 10 Years Follow-Up [10]Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations